Transferreagenz, in vivo-jetPEI®-Man

Lieferant: Polyplus-transfection
101000009.EA 790 EUR
PPLU101000009
Transferreagenz, in vivo-jetPEI®-Man
in vivo-jetPEI®-Man ist ein Mannose-konjugiertes in vivo-jetPEI™ Derivat zur Verbesserung des Transfers in Zellen, die Mannose-spezifische Membranrezeptoren exprimieren.

  • Suitable for in vivo delivery of any nucleic acid
  • Very simple to use: Two-step protocol
  • Safe: No inflammatory response triggered
  • Protocols tailored for your application by Polyplus-transfection® delivery experts

Zertifizierungen: Polyplus-transfection® has been an ISO 9001 accredited company since 2002. Since then this certification has been successfully renewed every three years.

Each lot of in vivo-jetPEI®-Man is validated by DNA (pCMV-Luciferase) delivery into mouse through intravenous injection. The amount of luciferase (ng) per mg of protein is indicated on the Certificate of Analysis for each lot of reagent. Moreover, absence of endotoxin is verified in every lot of in vivo-jetPEI®-Man.

Lieferumfang: 10% Glucose-Lösung ist im Umfang enthalten. 0,1 ml in vivo-jetPEI®-Man Transferreagenz reicht für bis zu 20 intravenöse Injektionen in Mäusen mit 50 µg DNA aus.
Bestellen

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR